Withdrawal of all medications is not necessary for accurate screening for primary aldosteronism: preliminary results

Pol Arch Intern Med. 2021 Jun 29;131(6):578-581. doi: 10.20452/pamw.16016. Epub 2021 May 31.

Authors

Agnieszka Łebek-Szatańska¹, Lucyna Papierska², Piotr Glinicki², Wojciech Zgliczyński²

Affiliations

¹ Department of Endocrinology, Center of Postgraduate Medical Education, Bielanski Hospital, Warsaw, Poland. agalebek@gmail.com
² Department of Endocrinology, Center of Postgraduate Medical Education, Bielanski Hospital, Warsaw, Poland

PMID: 34057324
DOI: 10.20452/pamw.16016

No abstract available

Publication types

Letter

MeSH terms

Antihypertensive Agents / therapeutic use
Humans
Hyperaldosteronism* / diagnosis
Hyperaldosteronism* / drug therapy
Hypertension* / drug therapy
Mass Screening

Substances

Antihypertensive Agents